Intrexon Actobiotics

Active

Public limited companyfounded 2006active for 20 yearsOudenaardseheerweg 129, 9810 Nazareth-De Pinte, Belgium10 active companies are registered at this addressKBO/BCE: BE 0882.251.820

Summary

Intrexon Actobiotics has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8.6m and a net result of -€372,153. Equity is shrinking by about 4.9% per year across the filed financial years. Its solvency ranks better than 95% of 239 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow Report Compare

Intrexon ActobioticsActiveChecked score 93/100

Risk analysis Report Compare

Activity

Research and development on biotechnology

NACE 72101

8th largest company by equity in Nazareth-De Pinte, Professional and technical services sector1 site

Size

€8.8mtotal assets 2025

Equity: €8.6m
Loss: -€372,153

Net result +85%: other schema

Financial health

93 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.1%

Structure

Parent: ACTOBIO LABORATORIES BELGIUM · 99.99%

Rutul ShahDirector

Auditor: DELOITTE Bedrijfsrevisoren BV2025 accounts 28 days early3 of 42 deeds summarised

Why 93raises riskLiquidity: current ratio 54.53, cash €70,9541 of the last 3 lateLoss of €372,153, the second in a row (financial year 2025)lowers riskSize: total assets €8.8mShow the evidence

Checked score

Score 2025

93 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 49% of its sector peers (NACE 72, small)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Average

Solvency 100=

equity 98.0% of total assets

Liquidity 51+1

short-term debt 1.8% · cash 0.8%

Profitability 27+27

return on assets -4.2%

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (165 companies, NACE 72, small)

Last 24 months 11-2024: 0.6% 12-2024: 0.6%● unchanged vs 11-2024 01-2025: 0.6%● unchanged vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.6%● unchanged vs 03-2025 05-2025: 0.6%● unchanged vs 04-2025 06-2025: 0.6%● unchanged vs 05-2025 07-2025: 0.7%▲ +0.1 percentage points vs 06-2025 08-2025: 1.9%▲ +1.2 percentage points vs 07-2025 09-2025: 1.9%● unchanged vs 08-2025highest value 10-2025: 1.9%● unchanged vs 09-2025highest value 11-2025: 1.9%● unchanged vs 10-2025highest value 12-2025: 1.9%● unchanged vs 11-2025highest value 01-2026: 1.9%● unchanged vs 12-2025 02-2026: 1.9%● unchanged vs 01-2026 03-2026: 1.9%● unchanged vs 02-2026 04-2026: 1.9%● unchanged vs 03-2026 05-2026: 1.8%▼ -0.1 percentage points vs 04-2026 06-2026: 1.9%▲ +0.1 percentage points vs 05-2026 07-2026: 1.8%▼ -0.1 percentage points vs 06-2026 08-2026: 0.3%▼ -1.5 percentage points vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.1%▼ -0.2 percentage points vs 09-2026lowest value

Credit of up to €750,000 on 30-day terms is acceptable

Liquidity ample (current ratio 54.53, compared with 89.94 in 2024, above the usual 1.5; short-term debt: 1.8% and cash: 0.8% of total assets), and 2% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, small): better than 85% on solvency, 42% on liquidity, 39% on profitability and 29% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Liquidity: current ratio 54.53, cash €70,954

NBB · annual accounts

Size: total assets €8.8m

Companies of this size fail less often; how much that weighs depends on the rest of its profile.

NBB · annual accounts

1 of the last 3 late

NBB · filings

Loss of €372,153, the second in a row (financial year 2025)

NBB · annual accounts

Persistent losses

Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2025

Net result per financial year

1819202122232425

2018 to 2025 · latest year -€372,153

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

28 days early

2024

3 days early

2023

63 days late

2022

13 days early

2021

13 days early

2020

12 days early

2019

36 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 6 days before the deadline; the sector median (NACE 72) for financial year 2024 is 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 July (4 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

25-10-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

03-07-2026 Annual accounts filedfinancial year 2025 · full…
22-05-2026 Reappointment: Deloitte Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Pieter-Jan Van Durme
28-07-2025 Annual accounts filedfinancial year 2024 · abbreviated…

Key points

Positive: Result rose in 2025different schema filed ▲ 85.2% View
Positive: Among the best 6% on solvencysector median 49.2% · 239 companies 98.0% View
Controlled by ACTOBIO LABORATORIES BELGIUMultimately: Precigen Inc. 99.99% View
Caution: 2 loss-making years in a rowloss financial year 2025 -€372,153 View

By topic

Financials

Financial year: 2025
Total assets: €8.8m
Loss: -€372,153
Solvency: 98.0%

Turnover▼ 26.6%

Net result

20182022

Go to Financials

Board & ownership

Board: 1 member
Parent: ACTOBIO LABORATORIES BELGIUM · 99.99%
Auditor: DELOITTE Bedrijfsrevisoren BV

Rutul ShahDirector

Go to Board & ownership

Network & group

Group: Precigen Inc.

Go to Network & group

Timeline

Events: 26
Since: 2008
Next accounts: by 31-07-2027

31-12-2024Weakest financial year
31-12-2024Liquidity more than 9 times
08-10-2024Permanent representative: Pieter Rottiers

Go to Timeline

Company details

Sites: 1

Legal form: Public limited company
Activity: Research and development on biotechnologyNACE 72101
Founded: 03-07-2006
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Articles of association

Provisions read: 11

Annual meeting: Third Wednesday of May at 10:00
Purpose: “Alle verrichtingen die betrekking hebben op…” (deed in Dutch)

Go to Articles of association

Key facts about Intrexon Actobiotics

What is the company number of Intrexon Actobiotics?: 0882.251.820. In Belgium the VAT number is the company number with BE in front: BE 0882.251.820.
Where is Intrexon Actobiotics based?: The registered office is at Oudenaardseheerweg 129, 9810 Nazareth-De Pinte.Company details
What does Intrexon Actobiotics do?: According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of Intrexon Actobiotics?: Public limited company (NV).
When was Intrexon Actobiotics founded?: On 03-07-2006.
Is Intrexon Actobiotics still active?: Yes, Intrexon Actobiotics is an active enterprise in the KBO register.
How many employees does Intrexon Actobiotics have?: On average 10.9 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of Intrexon Actobiotics?: €6.1m in financial year 2022, according to the filed annual accounts.
Is Intrexon Actobiotics profitable?: In financial year 2025, Intrexon Actobiotics made a loss of €372,153.
Where can I find the annual accounts of Intrexon Actobiotics?: Intrexon Actobiotics filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Intrexon Actobiotics due?: By 31-07-2027, for financial year 2026.Timeline